Mark,
Not only will MD's not know about it, but 99.9% of the general public does/will not. That is a big challenge ahead for BIEL to provide the exposure to the product, which will take time. Partnerships developed in the US will help provide the education that is needed...such as NHS. As mentioned by Paul, once the "cash loosens up", PR campaigns can begin, and a big name hospital being worked with help the PR. General public OTC strategy is secondary at the moment according to mgmt. FDA approval will help in many different ways, but is doesn't tell the public about the product.
A lot of positive action on the horizon, but IF to become a household name, or gain widespread recognition for that matter will take a few years....IMO.. thats me thinking?? :-). Much needed revenue to be made in the next 12 months as our current operations mature and future stages are developed. Pressure is building, as all can feel. Very excited about he future.
Yes, a "head scratcher" for me being at .0029.
In for the long haul.
News 
Market Data 
Discover 
